ODTX Odyssey Therapeutics, Inc.
$24.63▲ +4.19%
Healthcare
Other
After hours
$24.63▲ +0.00%
Sep 11, 7:30 PM ET
Volume 198.4K
Avg Volume (10D) 181.7K
Key Metrics & Fundamentals
Market Cap
$1.18B
P/E Ratio
–
Div Yield
–%
52W Range
15.10 - 29.05
% vs 50 MA
17.07%
% vs 200 MA
–%
RSI-14
52.8
MACD Histogram
-0.3400
Beta (1Y vs SPY)
1.46
Free Cash Flow
-$34.69M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$43.00M
COGS
–
Operating Exp
$46.74M
Operating Income
-$46.74M
EBIT
-$46.74M
Pretax Income
-$52.80M
Net Income
-$52.79M
EPS (Diluted)
-1.74
Price & Volume History
Loading chart…
Recent News
HC Wainwright Initiates Odyssey Therapeutics at Buy With $44 Price Target
MT Newswires · Aug 27, 2026 11:33 AM
Odyssey Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire · Aug 26, 2026 12:00 PM
Odyssey Therapeutics (ODTX) Looks Fully Valued As Earnings And Evotec Deal Refocus Attention
Simply Wall St. · Aug 11, 2026 12:19 AM
Evotec and Odyssey collaborate on AI-enabled R&D
Pharmaceutical Technology · Aug 7, 2026 10:10 AM
Odyssey Therapeutics: Q2 Earnings Snapshot
Associated Press · Aug 6, 2026 10:32 AM
Evotec, Odyssey Therapeutics Partner to Develop Autoimmune, Inflammatory Disease Treatments
MT Newswires · Aug 6, 2026 8:30 AM
Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases
PR Newswire · Aug 6, 2026 6:16 AM
Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire · Aug 4, 2026 11:00 AM
Kardigan rises in Nasdaq debut after upsized $400 million IPO
Reuters · Jun 18, 2026 4:56 PM
Odyssey Therapeutics: Q1 Earnings Snapshot
Associated Press · Jun 17, 2026 8:51 PM
Financial Overview - Income Statement
Quarterly
Jun 2025
See ODTX's money flow as a full page
Social Sentiment
No Reddit posts found for ODTX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.